ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
8.27
-0.23 (-2.71%)
At close: May 15, 2026, 4:00 PM EDT
8.28
+0.01 (0.12%)
After-hours: May 15, 2026, 7:59 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$788,043
Profits / Employee
$255,570
Market Cap
1.92B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 605 |
| Lakefront Biotherapeutics NV | 558 |
| Intellia Therapeutics | 377 |
| Ocular Therapeutix | 325 |
| Stoke Therapeutics | 170 |
| Pharvaris | 129 |
| Aurinia Pharmaceuticals | 128 |
ADMA News
- 1 day ago - ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law - GlobeNewsWire
- 5 days ago - $ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money - GlobeNewsWire
- 8 days ago - $ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 8 days ago - Adma Biologics price target lowered to $20 from $24 at Mizuho - TheFly
- 9 days ago - ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors - Newsfile Corp
- 9 days ago - Adma Biologics price target lowered to $18 from $21 at Canaccord - TheFly
- 9 days ago - Adma Biologics options imply 12.3% move in share price post-earnings - TheFly
- 9 days ago - Adma Biologics reports Q1 EPS 19c, consensus 20c - TheFly